A lactating woman presenting with puerperal pneumococcal mastitis: a case report

Journal of Medical Case Reports

Mark Miller²  Barbara Miedzybrodzki¹ 

[1] Division of Internal Medicine, Jewish General Hospital, 3755 Cote-Ste-Catherine, Montreal, Quebec H3T 1E2, Canada;Division of Infectious Diseases, Jewish General Hospital, 3755 Cote-Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada

关键词: Pneumococcal vaccine;    Streptococcus pneumoniae;    Puerperal mastitis;    Pneumococcal infection;    Mastitis;   

Others  :  1181205
DOI  :  10.1186/1752-1947-7-114

 received in 2012-11-25, accepted in 2013-03-26,  发布年份 2013

【 摘 要 】

Introduction

Streptococcus pneumoniae is an uncommon etiologic agent in soft-tissue infections.

Case presentation

We report the case of a 35-year-old Caucasian woman who presented to our facility with puerperal pneumococcal mastitis, and review the only other three cases of pneumococcal mastitis described in the medical literature.

Conclusions

The roles of the various pneumococcal vaccines in preventing this disease are discussed.

【 授权许可】

   
2013 Miedzybrodzki and Miller; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Foxman B, D'Arcy H, Gillespie B, Bobo JK, Schwartz K: Lactation mastitis: occurrence and medical management among 946 breastfeeding women in the United States. Am J Epidemiol 2002, 155:103-114.
• [2]World Health Organization: Mastitis: Causes and Management. WHO/FCH/CAH/00.13. Geneva, Switzerland: WHO; 2000.
• [3]DiNubile MJ, Albornoz A, Stumacher RJ, Van Uitert BL, Paluzzi SA, Bush LM, Nelson SL, Myers AR: Pneumococcal soft-tissue infections: possible association with connective tissue diseases. J Infect Dis 1991, 163:897-900.
• [4]Wüst J, Rutsch M, Stocker S: Streptococcus pneumoniae as an agent of mastitis. Eur J Clin Microbiol Infect Dis 1995, 14:156-157.
• [5]Kragsbjerg P, Noren T, Soderquist B: Deep soft-tissue infections caused by Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 1995, 14:1002-1004.
• [6]Garcia-Lechuz JM, Cuevas O, Castellares C, Perez-Fernandez C, Cercenado E, Bouza E: Streptococcus pneumoniae skin and soft tissue infections: characterization of causative strains and clinical illness. Eur J Clin Microbiol Infect Dis 2007, 26:247-255.
• [7]Public Health Aganecy of Canada: Publicly funded Immunization Programs in Canada - Routine Schedule for Infants and Children (including special programs and catch-up programs). http://www.phac-aspc.gc.ca/im/ptimprog-progimpt/table-1-eng.php webcite
• [8]Reinert RR, Jacobs MR, Kaplan S: Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine 2010, 28:4249-4259.
• [9]Griffith A, Demczuk W, Martin I, Shane A, Tyrrell G, Gilmour MW, the Canadian Public Health Laboratory Network: Distribution of invasive pneumococcal serotypes in Canada: 2010–2011. Abstract #K4. Vancouver, Canada: AMMI Canada - CACMID Annual Conference; 2012.
• [10]Bryant KA, Block SL, Baker SA, Gruber WC, Scott DA, PCV13 Infant Study Group: Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine. Pediatrics 2010, 125:866-875.